NewAmsterdam Pharma Company N.V. logo NAMS - NewAmsterdam Pharma Company N.V.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 9
HOLD 1
SELL 0
STRONG
SELL
0
| PRICE TARGET: $46.00 DETAILS
HIGH: $55.00
LOW: $37.00
MEDIAN: $46.00
CONSENSUS: $46.00
UPSIDE: 29.80%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Revenue
Revenue 3.0 0.0 0.3 19.1 3.0 12.8 29.1 2.3 1.4 0.8 2.9 1.7 8.6 5.5 5.5 49.0 51.7 0 0 0 0 0 0 0 0
Cost of Revenue 0.5 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 2.5 (0.0) 0.3 19.1 3.0 12.8 29.1 2.3 1.4 0.8 2.9 1.7 8.6 5.5 5.5 49.0 51.7 0 0 0 0 0 0 0 0
Operating Expenses
R&D Expenses 37.5 38.6 31.0 27.5 44.8 34.9 35.7 38.4 42.4 41.3 43.4 34.3 40.4 28.4 28.4 16.0 16.9 9.9 9.5 5.1 5.0 0 1.0 1.0 1.0
SG&A Expenses 23.4 27.4 24.5 27.3 27.2 24.3 17.3 15.3 14.5 8.7 9.1 9.9 6.8 5.2 5.2 4.9 5.1 1.9 0.7 0.8 0.8 0.1 0.3 0.3 0.3
Other Expenses 0 0 0 0 0 (3.2) 1.1 1.2 0 1.9 0 0 1.2 0 0 0.0 0.0 6.3 7.1 0 0.0 0 (2.7) (2.7) (2.7)
Operating Expenses 61.0 66.0 55.5 54.8 71.9 56.0 54.1 54.9 56.9 51.9 52.5 44.2 48.5 33.6 33.6 20.9 22.1 18.0 17.3 5.9 5.8 0.1 (1.4) (1.4) (1.4)
Operating Income
Operating Income (58.4) (66.0) (55.1) (35.6) (68.9) (43.2) (25.0) (52.6) (55.5) (51.1) (49.6) (42.5) (39.9) (28.1) (28.1) 28.1 29.7 (18.0) (17.3) (5.9) (5.8) (0.1) (1.4) (1.4) (1.4)
Interest Expense 0 0 0 0 0 0 0 0 0 1.7 1.0 3.1 1.2 0.0 0 0 0 0 0 0 0 0 0.1 0.1 0.1
Interest Income 4.0 6.5 6.7 7.1 7.4 4.5 4.4 4.9 3.1 2.5 2.7 4.2 0.9 0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0 0 0
Profitability
EBITDA (58.4) (65.9) (71.9) (35.6) (68.9) (111.7) (23.8) (51.4) (55.5) (51.0) (49.5) (42.5) (38.6) (28.1) (28.1) 28.1 29.7 (12.4) (11.5) (5.9) (5.8) 0.0 (1.4) (1.4) (1.4)
EBIT (58.4) (66.0) (72.0) (35.6) (68.9) (111.7) (23.9) (51.4) (55.5) (51) (49.6) (42.5) (38.6) (28.1) (28.1) 28.1 29.7 (12.4) (11.5) (5.9) (5.8) 0.0 (1.4) (1.4) (1.4)
Income Before Tax (48.4) (74.9) (72.0) (17.4) (39.5) (92.2) (16.6) (39.0) (93.8) (49.5) (47.1) (38.3) (42.0) (38.0) (38.0) 28.6 30.2 (20.1) (11.1) (5.6) (5.6) 0.0 (1.4) (1.4) (1.4)
Income Tax Expense 0 0 0 0 0 0 (0.0) 0 0 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (48.4) (74.9) (72.0) (17.4) (39.5) (92.2) (16.6) (39.0) (93.8) (49.5) (47.1) (38.3) (42.0) (38.0) (38.0) 28.6 30.2 (20.1) (11.1) (5.6) (5.6) 0.0 (1.4) (1.4) (1.4)
Per Share Data
EPS (Basic) -0.40 -0.65 -0.61 -0.15 -0.34 -0.98 -0.18 -0.41 -1.06 -0.52 -0.56 -0.43 -0.47 -2.20 -23.19 0.75 0.75 -1.73 -0.82 -0.43 -0.43 0.00 -0.02 -0.02 -0.02
EPS (Diluted) -0.40 -0.65 -0.61 -0.15 -0.34 -0.98 -0.18 -0.41 -1.06 -0.52 -0.56 -0.43 -0.47 -2.20 -23.22 0.67 0.68 -1.73 -0.82 -0.43 -0.43 0.00 -0.02 -0.02 -0.02
Shares Outstanding 121.1 114.4 119.0 112.5 116.1 97.0 94.8 94.7 82.2 82.5 82.5 81.8 81.6 18.4 17.8 17.8 17.8 17.8 17.8 17.8 17.8 17.8 86.1 86.1 86.1
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q2 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Current Assets
Cash & Cash Equivalents 457.6 490.0 538.4 563.9 748.4 771.7 422.7 430.7 481.1 340.4 418.7 467.7 467.7 93.7 0.7 60.4 0.6 0.8 1.2 1.4 2.0 2.0 2.0
Short-Term Investments 178.5 146.2 164.5 175.3 60.1 62.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Receivables 8.2 23.2 20.2 0 1.6 21.3 5.1 0 0 0 0 0 0 120.5 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 1.3 1.3 1.3 19.8 0 0 0 5.4 4.1 1.9 0 2.1 2.1 1.7 0.2 4.9 0 0 0 0 0.3 0.3 0.3
Total Current Assets 658.0 675.7 732.3 769.9 817.3 863.4 437.9 445.4 487.8 346.8 425.0 478.0 478.0 227.3 0.9 67.0 1.0 1.2 1.6 1.9 2.3 2.3 2.3
Non-Current Assets
Property, Plant & Equipment 0.4 0.6 0.6 0.6 0.6 0.7 0.7 0.8 0.1 0.1 0.1 0.2 0.2 0.2 0 0.2 0 0 0 0 0.0 0.0 0.0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0.4 0.4 0.4 0.5 0.5 0.5 0.6 0.5 0.5 0.2 0 0.2 0.2 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 53.1 44.2 0 0 0 0 0 0 0 0 0 0 124.7 0 138.0 138.0 138.0 138.0 0 0 0
Other Non-Current Assets 73.8 92.6 0 0 0 0 0 0.0 0.0 0.0 89.2 0.2 0.2 0.8 0 0.8 0 0 0 0 0 0 0
Total Non-Current Assets 74.6 93.6 54.1 45.3 1.1 1.2 1.3 1.3 0.6 0.3 89.3 0.5 0.5 0.9 124.7 1.0 138.0 138.0 138.0 138.0 0.0 0.0 0.0
Total Assets 732.6 769.3 786.4 815.1 818.4 864.6 439.2 446.7 488.5 347.1 514.3 478.5 478.5 228.2 125.7 68.0 139.0 139.2 139.6 139.9 2.3 2.3 2.3
Current Liabilities
Account Payables 8.1 9.0 3.6 5.9 6.1 4.7 7.0 5.3 8.5 16.9 22.8 11.9 11.9 12.3 0 7.1 0 0 0 0.2 0.1 0.1 0.1
Short-Term Debt 0.0 0.1 0.2 0 0.3 0.2 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0 2.9 2.9 2.9
Deferred Revenue 4.0 4.0 0 0 3.0 6.0 4.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 55.3 72.7 48.6 20.9 29.6 91.0 29.5 29.6 41.2 21.5 19.0 18.0 18.0 14.7 0.1 0 0.2 0.1 0.2 0.1 0.2 0.2 0.2
Total Current Liabilities 67.4 85.8 58.3 36.5 40.9 106.9 41.3 45.3 59.7 49.9 41.9 36.1 36.1 27.1 0.1 11.2 0.2 0.1 0.2 0.2 3.2 3.2 3.2
Non-Current Liabilities
Long-Term Debt 0 0.1 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 18.8 13.6 16.9 8.8 11.4 12.3 12.3 7.8 5.4 0 8.0 10.1 9.1 12.2 0 0 0
Total Non-Current Liabilities 0 0.1 0.1 0.1 0.1 0.2 19.1 13.9 16.9 8.8 11.5 12.4 12.4 7.9 5.4 0.1 8.0 10.1 9.1 12.2 0 0 0
Total Liabilities 67.4 85.9 58.4 36.6 41.0 107.1 60.3 59.3 76.7 58.7 53.3 48.4 48.4 35.0 5.5 11.4 8.3 10.2 9.4 12.4 3.2 3.2 3.2
Stockholders' Equity
Common Stock 14.6 14.3 14.1 14.0 14.0 13.4 11.4 11.2 11.1 10.2 10.8 10.1 10.1 0.2 124.7 0.1 138.0 124.0 125.3 122.5 0.6 0.6 0.6
Retained Earnings (810.8) (762.4) 0 (615.5) (598.1) 0 (466.4) (449.7) (410.7) (317.0) (212.3) (140.0) (140.0) 20.8 (4.5) (39.4) (7.3) 1.6 2.9 0.0 (1.5) (1.5) (1.5)
Accumulated Other Comprehensive Income 4.2 4.8 4.6 4.3 4.4 4.5 4.4 4.4 4.4 4.4 8.7 4.4 4.4 1.1 0 0.7 0 0 0 0 (0.0) (0.0) (0.0)
Total Stockholders' Equity 665.2 683.4 728.1 778.5 777.4 757.5 378.9 387.4 411.8 288.4 461.0 430.1 430.1 193.2 120.2 56.6 130.7 129.0 130.3 127.5 (0.9) (0.9) (0.9)
Total Liabilities & Equity 732.6 769.3 786.4 815.1 818.4 864.6 439.2 446.7 488.5 347.1 514.3 478.5 478.5 228.2 125.7 68.0 139.0 139.2 139.6 139.9 2.3 2.3 2.3
Debt Metrics
Total Debt 0.0 0.2 0.3 0.3 0.4 0.4 0.5 0.6 0.0 0.1 0.1 0.1 0.1 0.2 0 0.2 0.0 0.0 0 0 2.9 2.9 2.9
Net Debt (457.6) (489.8) (538.1) (563.5) (748.0) (771.3) (422.2) (430.1) (481.1) (340.4) (418.6) (467.6) (467.6) (93.6) (0.7) (60.2) (0.6) (0.8) (1.2) (1.4) 0.9 0.9 0.9
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Operating Activities
Net Income (48.4) (74.9) 39.5 0 (39.5) (92.2) (16.6) (39.0) (93.8) (49.5) (46.1) (38.3) (42.0) (40.4) (4.8) (1.2) 1.4 0.9 1.7 (1.3) 2.8 (1.4) (1.4) (1.4) (1.4)
Depreciation & Amortization 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 (0.0) 0 0 0 0 0 0 0 0.0 0.0 0.0 0.0
Stock-Based Compensation 0 0 15.0 15.2 15.2 9.4 0 8.3 7.9 6.0 5.6 5.6 7.6 1.9 0 0 0 0 0 0 0 0 0 0 0
Change in Working Capital 4.1 4.6 (10.4) (23.8) 10.4 (8.0) 0.0 (14.6) (10.1) 9.3 2.6 3.0 (0.6) 58.6 2.1 1.8 (0.0) 0.0 0.2 (0.1) 0.0 (0.1) (0.1) (0.1) (0.1)
Other Non-Cash Items 13.7 29.4 (77.0) (29.1) (22.6) 53.2 4.1 (8.7) 41.4 1.1 2.6 0.4 3.1 9.2 2.5 (0.8) (1.7) (0.4) (2.1) 1.0 (3.1) 0.1 0.1 0.1 0.1
Operating Cash Flow (30.6) (40.9) (32.8) (37.7) (36.5) (37.5) (12.5) (54.0) (54.6) (33.1) (35.3) (29.3) (31.9) 29.2 (0.2) (0.2) (0.4) 0.6 (0.2) (0.4) (0.2) (1.5) (1.5) (1.5) (1.5)
Investing Activities
Capital Expenditure (0.0) (0.1) (0.0) (0.1) (0.0) (0.0) (0.1) (0.2) (0.4) (0.0) (0.0) (0.0) (0.0) (0.1) 0.0 0.0 (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0)
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (62.5) (71.5) (31.9) (183.7) (9.6) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 51 50.5 34.4 24.7 12.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 (62.2) 0 0 0 0 (2.6) 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0.0 0.0
Investing Cash Flow (11.5) (21.1) 2.5 (159.1) 2.9 (62.2) (0.1) (0.2) (0.4) (0.0) (2.6) (0.0) (0.0) (0.1) 0 0 0 0 0 0 0 (0.0) (0.0) (0.0) (0.0)
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 0 0 6.5 1.6 0 0 7.7 0 0.2 6.3 2.4 153.4 0 0 0 0 0 0 0 2.8 2.8 2.8 2.8
Financing Cash Flow 11.1 13.7 5.9 3.4 6.5 456.6 0.1 4.7 198.2 0 0.2 6.3 2.4 153.4 0 0 (0.0) 0 0 0 0 2.8 2.8 2.8 2.8
Cash Position
Net Change in Cash (32.4) (48.4) (24.1) (184.6) (23.3) 349.0 (8.0) (50.4) 140.7 (27.9) (32.7) (24.6) (26.4) 0 (0.2) (0.2) (0.4) 0.6 (0.2) (0.4) (0.2) 1.3 1.3 1.3 1.3
Cash at Beginning 491.3 539.7 563.9 748.4 771.7 422.7 430.7 481.1 340.4 368.3 381.9 441.3 467.7 0 0.6 0.8 1.2 0.6 0.8 1.2 1.4 0.6 0.6 0.6 0.6
Cash at End 458.9 491.3 539.7 563.9 748.4 771.7 422.7 430.7 481.1 340.4 349.2 416.7 441.3 0 0.4 0.6 0.8 1.2 0.6 0.8 1.2 2.0 2.0 2.0 2.0
Free Cash Flow (30.6) (41.0) (32.8) (37.8) (36.5) (37.5) (12.6) (54.2) (55.0) (33.1) (35.3) (29.3) (31.9) 29.1 (0.2) (0.2) (0.4) 0.6 (0.2) (0.4) (0.2) (1.5) (1.5) (1.5) (1.5)
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Income Statement
Revenue 3.0 0.0 0.3 19.1 3.0 12.8 29.1 2.3 1.4 0.8 2.9 1.7 8.6 5.5 5.5 49.0 51.7 0 0 0 0 0 0 0 0
Gross Profit 2.5 (0.0) 0.3 19.1 3.0 12.8 29.1 2.3 1.4 0.8 2.9 1.7 8.6 5.5 5.5 49.0 51.7 0 0 0 0 0 0 0 0
Operating Income (58.4) (66.0) (55.1) (35.6) (68.9) (43.2) (25.0) (52.6) (55.5) (51.1) (49.6) (42.5) (39.9) (28.1) (28.1) 28.1 29.7 (18.0) (17.3) (5.9) (5.8) (0.1) (1.4) (1.4) (1.4)
Net Income (48.4) (74.9) (72.0) (17.4) (39.5) (92.2) (16.6) (39.0) (93.8) (49.5) (47.1) (38.3) (42.0) (38.0) (38.0) 28.6 30.2 (20.1) (11.1) (5.6) (5.6) 0.0 (1.4) (1.4) (1.4)
EPS (Diluted) -0.40 -0.65 -0.61 -0.15 -0.34 -0.98 -0.18 -0.41 -1.06 -0.52 -0.56 -0.43 -0.47 -2.20 -23.22 0.67 0.68 -1.73 -0.82 -0.43 -0.43 0.00 -0.02 -0.02 -0.02
Balance Sheet
Cash & Equivalents 457.6 490.0 538.4 563.9 748.4 771.7 422.7 430.7 481.1 340.4 418.7 467.7 467.7 93.7 0.7 60.4 0.6 0.8 1.2 1.4 2.0 2.0 2.0
Total Assets 732.6 769.3 786.4 815.1 818.4 864.6 439.2 446.7 488.5 347.1 514.3 478.5 478.5 228.2 125.7 68.0 139.0 139.2 139.6 139.9 2.3 2.3 2.3
Total Debt 0.0 0.2 0.3 0.3 0.4 0.4 0.5 0.6 0.0 0.1 0.1 0.1 0.1 0.2 0 0.2 0.0 0.0 0 0 2.9 2.9 2.9
Stockholders' Equity 665.2 683.4 728.1 778.5 777.4 757.5 378.9 387.4 411.8 288.4 461.0 430.1 430.1 193.2 120.2 56.6 130.7 129.0 130.3 127.5 (0.9) (0.9) (0.9)
Cash Flow
Operating Cash Flow (30.6) (40.9) (32.8) (37.7) (36.5) (37.5) (12.5) (54.0) (54.6) (33.1) (35.3) (29.3) (31.9) 29.2 (0.2) (0.2) (0.4) 0.6 (0.2) (0.4) (0.2) (1.5) (1.5) (1.5) (1.5)
Capital Expenditure (0.0) (0.1) (0.0) (0.1) (0.0) (0.0) (0.1) (0.2) (0.4) (0.0) (0.0) (0.0) (0.0) (0.1) 0.0 0.0 (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0)
Free Cash Flow (30.6) (41.0) (32.8) (37.8) (36.5) (37.5) (12.6) (54.2) (55.0) (33.1) (35.3) (29.3) (31.9) 29.1 (0.2) (0.2) (0.4) 0.6 (0.2) (0.4) (0.2) (1.5) (1.5) (1.5) (1.5)